Contents
Download PDF
pdf Download XML
389902 Views
30874 Downloads
Share this article
Research Article | Volume 25 Issue 1 (, 2019) | Pages 62 - 65
Triple Percutaneous Mitral Balloon Valvuloplasty for Patients with Recurrent Mitral Valve Stenosis: Long-Term Observations
 ,
 ,
 ,
 ,
 ,
 ,
 ,
1
Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.
2
Department of Congenital Cardiac Defects, Institute of Cardiology, Warsaw, Poland.
Under a Creative Commons license
PMID : -27989086
Published
Jan. 11, 2016
Abstract

Background: A third percutaneous mitral balloon valvuloplasty (PMBV) may provide a means of treating symptomatic patients with re-restenosis after successful initial and second valvuloplasties, though data related to the long-term safety and efficacy of a third PMBV are lacking. The study aim was to determine the immediate and long-term clinical outcome in patients who underwent a third PMBV to treat recurrent mitral stenosis.

Methods: Among a total of 1,849 patients who underwent PMBV at the authors' institution, seven females (mean age 38.5 ± 12.2 years at the first procedure) required repeat second and third PMBVs. The mean interval between the first and second valvuloplasties was 6.4 ± 2.5 years, and between the first and third valvuloplasties was 12.5 ± 6.5 years. All procedures were performed using the Inoue balloon system.

Results: Second and third PMBVs resulted in a significant increase in mitral valve area (MVA), from 1.1 ± 0.1 cm2 to 1.6 ± 0.2 cm2, and from 1.0 ± 0.2 cm2 to 1.6 ± 0.4 cm2, respectively. However, as mitral degeneration progressed, four patients required mitral valve replacement (MVR) at 9.2 ± 5.8 years (range: 6-18 years) after the third PMBV. The preoperative MVA of these patients was 0.97 ± 0.1 cm2. One patient died due to surgical complications, while the fifth and sixth patients remain under clinical observation. If patients have a fourth recurrence of mitral stenosis they are no longer considered to be suitable candidates for re-PMBV. The seventh patient died at the age of 84 years.

Conclusions: A repeat, third PMBV is a safe and feasible procedure in selected patients with recurrent stenosis after successful first and second valvuloplasties. Although the third procedure provides good immediate results, the long-term outcome is not satisfactory. Nonetheless, a third PMBV would allow MVR surgery to be postponed for a few years.

 

 

 

How to cite: Tyczyński, P., Chmielak, Z., Rużyłło, W., Fronczak, A., Kłopotowski, M., Szymański, P., Konka, M., & Witkowski, A. (2016). Triple Percutaneous Mitral Balloon Valvuloplasty for Patients with Recurrent Mitral Valve Stenosis: Long-Term Observations. The Journal of heart valve disease25(1), 62–65.

 
Keywords
Recommended Articles
Research Article
Role of Metformin in Modulating Serum Ghrelin Levels in Obesity
Published: 30/12/2023
Download PDF
Read Article
Research Article
Morphometric Analysis of the Human Mitral Valve: A Cadaveric Study
...
Published: 19/08/2025
Download PDF
Read Article
Research Article
Impact of Metformin Therapy on Serum Adiponectin Levels in Obese Individuals
Published: 14/08/2025
Download PDF
Read Article
Research Article
Prospective Study on Functional Outcome of CTEV By Ponseti Method of Cast Application
...
Published: 31/07/2025
Download PDF
Read Article
© Copyright Journal of Heart Valve Disease